Induced pluripotent stem cells (iPSCs) offer an invaluable tool for biological research and regenerative medicine. We report establishment of rat iPSCs (riPSCs) using a plasmid vector encoding four transcription factors, Oct3/4, Sox2, c-Myc and Klf4. Although all riPSC clones were generated and cultured under the same conditions, expressed hallmark pluripotency markers and differentiated successfully in vitro, the expression of a keratan sulfate glycan epitope with unique properties defined by R-10G antibody varied in the riPSC clones. In contrast, tumor rejection antigen (TRA)-1-81 epitope expression was comparable. A clone highly reactive to R-10G antibody formed teratomas in vivo consisting of cells from all three germ layers. However, clones expressing a lower level of the epitope defined by R-10G resulted in tumors with rapid growth consisting of undifferentiated cells. Additionally, riPSCs could be successfully differentiated into a neuronal lineage including glutamate neurons that responded to agonist stimulation. These observations demonstrate a glycophenotypic difference that may potentially serve as a useful probe for riPSC evaluation and to study the role of glycans in pluri potency and carcinogenesis in these cells.
Key words induced pluripotent stem cell; teratoma; R-10G antibody; glycobiologyThe generation of induced pluripotent stem cells (iPSC) by the forced expression of the exogenous transcription factors, Oct3/4, Sox2, c-Myc and Klf4, in mouse embryonic fibroblasts (MEFs) by Yamanaka's group paved way for a new era in stem cell research and regenerative medicine.1,2) Using reprogramming factors, iPSC have been successfully generated from humans and other mammalian species such as the rat [3][4][5] and monkey.1)The rat is utilized vastly as a model in pharmacology, toxicology, immunology research fields and behavioral science and has been useful in modeling human neural and cardiac system diseases.2) Rat iPSC lines have been derived from a variety of somatic cells mainly via viral transduction of reprogramming factors.3,4) The successful generation of transgenic rats using riPSC shows great promise in their use.
5)Variation in iPSC properties are widely reported 6) and definitive evaluation systems to assess riPSC pluripotency, differentiation propensity and potential for tumorigenesis still remain a challenge to the field. Glycans are considered to be ideal targets for identifying and analyzing cellular phenotype and cell surface epitopes such as stage-specific embryonic antigens (SSEA)-3/4 and tumor rejection antigen (TRA)-1-60/81 are conventionally used to evaluate pluripotency. However, these epitopes are also expressed in embryonal carcinoma (EC) cells. 7,8) In previous work, we generated the monoclonal antibody, R-10G, which recognizes a keratan sulfate epitope with unique structure on podocalyxin in human iPSC and human embryonal stem (ES) cells. 9) Notably, however, the antibody did not react with human EC cells that are known to be of a tumorigenic nature.Here we describe generation of...